Zero‑Shot Design of Drug‑Binding Proteins Demonstrates High Accuracy and Affinity

Date:

By pairing two neural networks in an iterative optimization algorithm, researchers have shown that small‑molecule binding proteins can be designed from scratch with high accuracy, strong affinity and impressive success rates, suggesting new possibilities for drug delivery and sequestration.

A study published online June 24, 2026 in Nature describes a “zero‑shot” approach that combines a protein‑structure prediction network with a ligand‑binding predictor in a loop of selection and expansion. The method generates candidate proteins, evaluates their predicted binding to target small molecules, and iteratively refines the designs without relying on existing protein templates.

In benchmark tests, the newly designed proteins bound a range of drug‑like compounds with nanomolar affinities, rivaling or exceeding those of naturally occurring binders. The success rate—measured as the proportion of designs that achieved measurable binding—was reported to be markedly higher than previous computational protein‑design pipelines.

The authors highlight several potential applications, including creating bespoke carriers for therapeutic agents, developing sequestration tools to neutralize toxins, and accelerating the discovery of protein‑based diagnostics. Because the workflow does not require prior structural data for a target, it could be applied to emerging drugs and small molecules where conventional design methods fall short.

Analysis: The study represents a significant advance in computational protein engineering by integrating deep‑learning models for structure and function in a closed‑loop system. If the reported affinities and success rates hold up in broader experimental validation, the technique could shorten development timelines for protein therapeutics and enable rapid response to novel drug targets. However, real‑world deployment will require extensive testing for stability, immunogenicity and manufacturability—factors not addressed in the initial publication.

Sources
– Nature, “Zero‑shot design of drug‑binding proteins via neural iterative selection‑expansion,” published online 24 June 2026, https://www.nature.com/articles/s41586-026-10670-w


Source: Nature – Original article

Corrections

If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.

Story synopsis gathered from: Nature — source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Breaking NASA Announces MAX POWER: America’s Newest Aerospace Expo, Airshow

NASA has unveiled plans for MAX POWER, a large-scale public exposition and airshow designed to showcase the current state and future trajectory of American air and space innovation. Scheduled for November 7 and 8, 2026, the event will be hosted…

Breaking NASA Competition Invites Students to Help Imagine a Future Enabled by Lunar Technologies

NASA has opened applications for the 2027 Revolutionary Aerospace Systems Concepts – Academic Linkage (RASC-AL) competition, challenging U.S.-based collegiate teams to design innovative operational paradigms and technologies for a sustainable lunar presence. The initiative seeks to bridge the gap between…

Breaking National Rail Faces Exceptional Challenges Amid Heatwave After Two Train Derailments

The United Kingdom's railway infrastructure is under severe strain as a series of extreme weather events trigger critical failures across the network. Within a single 24-hour window, two separate train derailments occurred in Essex and East Sussex, prompting Network Rail…

Breaking Hawaii Braces for Direct Hit from Tropical Storm Lala

Hawaii has declared a state of emergency as Tropical Storm Lala tracks toward a direct hit on the Big Island. Meteorologists warn that the system is likely to strengthen into a hurricane before landfall, bringing a combination of life-threatening flash…